Daily Patient's Relief From Pruritus and Sleep Disturbance Over One-Month Treatment with Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Multicenter Prospective Study
Dermatitis. 2024 Oct 3.
doi: 10.1089/derm.2024.0335.
Online ahead of print.